Clopidogrel 75 MG Oral Tablet [Plavix] — RxCUI 213169
RxNorm drug concept · Semantic branded drug
RxCUI 213169
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI213169
Official nameClopidogrel 75 MG Oral Tablet [Plavix]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPlavix 75 MG Oral Tablet; Plavix 75 MG (clopidogrel bisulfate 97.875 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)169 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clopidogrel: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Clopidogrel keeps platelets — the tiny blood cells that help form clots — from sticking together. That's important when you've had a heart attack, a stroke, or a procedure to open...
- What exactly is clopidogrel supposed to do for me?
- Good news — you can take clopidogrel with or without food, whichever is easier on your stomach. Food doesn't significantly change how well it works, so just pick a consistent time...
- Can I take it with food, or do I need to take it on an empty stomach?
🕸️ Concept Web — How Clopidogrel 75 MG Oral Tablet [Plavix] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clopidogrel 75 MG Oral Tablet [Plavix]
RxCUI 213169 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clopidogrel
32968IN
-
Clopidogrel
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Plavix
174742BN
-
Plavix
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clopidogrel Oral Tablet
374583SCDF -
Clopidogrel Oral Product
1163766SCDG -
Clopidogrel Pill
1163767SCDG -
Clopidogrel Oral Tablet [Plavix]
368301SBDF -
Plavix Oral Product
1181790SBDG -
Plavix Pill
1181791SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Clopidogrel Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clopidogrel 75 MG Oral Tablet
309362SCD -
Clopidogrel 75 MG
329449SCDC -
Clopidogrel 75 MG [Plavix]
573094SBDC
-
Clopidogrel 75 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clopidogrel 75 MG Oral Tablet
SCD · 309362 -
Clopidogrel 75 MG
SCDC · 329449 -
Clopidogrel Oral Tablet
SCDF · 374583 -
Clopidogrel Oral Product
SCDG · 1163766 -
Clopidogrel Pill
SCDG · 1163767
Brand-Name Concepts
-
Clopidogrel 75 MG [Plavix]
SBDC · 573094 -
Clopidogrel Oral Tablet [Plavix]
SBDF · 368301 -
Plavix Oral Product
SBDG · 1181790 -
Plavix Pill
SBDG · 1181791 -
Plavix
BN · 174742
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 213169 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00024-1171-90 | 90 TABLET, FILM COATED in 1 BOTTLE (0024-1171-90) | Plavix | Sanofi-Aventis U.S. LLC | 2020-07-13 |
| 00024-1332-30 | 3 BLISTER PACK in 1 CARTON (0024-1332-30) / 10 TABLET, FILM... | Plavix | Sanofi-Aventis U.S. LLC | 2020-07-13 |
Observed labelers:
Sanofi-Aventis U.S. LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.